DOI QR코드

DOI QR Code

Status Analysis of Adulterated Herbal Medicine

국내외 위변조 한약 현황 분석

  • Lee, Soojin (Department of Physiology, College of Korean Medicine, Sangji University)
  • 이수진 (상지대학교 한의과대학 생리학교실)
  • Received : 2020.09.14
  • Accepted : 2020.10.15
  • Published : 2020.10.25

Abstract

Adulterated herbal medicine is intentionally added with undeclared improper or inferior ingredients which should not be in herbal medicine. The contamination with potentially hazardous substances such as heavy metal, pesticides, fungus, and microorganism sometimes can be regarded as one of adulteration in a broad sense. The problem of adulteration is that adulterated herbal medicine shows poor quality and/or can cause adverse events. Therefore, it is important to control adulteration issues for quality assurance and qualitative improvement of herbal medicines. This study aims to summarize and make a reference how to control adulterated herbal medicine. In this process, this study is to investigate studies about adulterated herbal medicine via searching Korean and foreign electronic databases such as PubMed, NDSL and OASIS. Finally eighteen papers were included to this study and analyzed according to the type of study, the category and efficacy of adulterants, the type of analysis methodologies and possible adverse events of adulterants. Phosphodiesterase type 5 (PDE-5) inhibitors for male sexual enhancement and anorexic, laxative, diuretic agents for weight loss and treating obesity has been used frequently as adulterants. The range of adverse event caused by adulterated herbal medicine were very wide from mild symptoms such as diarrhea, constipation, dizziness and blurred vision to very severe symptoms such as heart failure, hypoglycemia and renal impairment. This study showed the recent trend on the research of adulterated herbal medicine and this will be the ground to develop more detailed systems to control adulterated herbal medicine.

Keywords

References

  1. World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. Geneva: World Health Organization; 2004.
  2. Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol. 2013;69:295-307. https://doi.org/10.1007/s00228-012-1353-z
  3. Xu M, Huang B, Gao F, Zhai C, Yang Y, Li L, et al. Assessment of Adulterated Traditional Chinese Medicines in China: 2003-2017. Front Pharmacol. 2019;10:1446. https://doi.org/10.3389/fphar.2019.01446
  4. Seeff LB, Bonkovsky HL, Navarro VJ, Wang G. Herbal Products and the Liver: A Review of Adverse Effects and Mechanisms. Gastroenterol. 2015;148:517-32. https://doi.org/10.1053/j.gastro.2014.12.004
  5. The Government of Hong Kong Special Administrative Re gion: Press Release. [Internet]. [cited 2020 Sep 02]. Availa ble from: https://www.info.gov.hk/gia/general/today.htm
  6. Singapore Health Sciences Authority: Announcement. [Internet]. [cited 2020 Sep 02]. Available from: https://www.hsa.gov.sg/announcements
  7. Australian Government Department of Health Therapeutic Goods Administration: Alerts. [Internet]. [cited 2020 Sep 02]. Available from: https://www.tga.gov.au/alerts
  8. Ahmed N, Nounou MI, Abouelfetouh A, El-Kamel A. Over-the-Counter Herbal Weight Loss Supplements in Egypt: Label Claim, Microbiological and Pharmaceutical Quality, and Safety Assessments. Med Princ Pract. 2019;28:167-77. https://doi.org/10.1159/000495986
  9. Ching CK, Lam YH, Chan AYW, Mak TWL. Adulteration of herbal antidiabetic products with undeclared pharmaceuticals: a case series in Hong Kong. Br J Clin Pharmacol. 2012;73:795-800. https://doi.org/10.1111/j.1365-2125.2011.04135.x
  10. Savaliya AA, Shah, RP, Prasad B, Singh S. Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC-MS/TOF. J pharmaceutical biomedical anal. 2010;52:406-9. https://doi.org/10.1016/j.jpba.2009.05.021
  11. Uchiyama N, Kikura-Hanajiri R, Goda Y. Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB1 and CB2 receptors. J Pharm Biomed Anal. 2010;51:705-11. https://doi.org/10.1016/j.jpba.2009.09.043
  12. Ren Y, Wu C, Zhang J. Simultaneous screening and determination of 18 illegal adulterants in herbal medicines and health foods for male sexual potency by ultra-fast liquid chromatography-electrospray ionization tandem mass spectrometry. J Sep Sci. 2012;35:2847-57. https://doi.org/10.1002/jssc.201200280
  13. Moreira AP, Motta MJ, Dal Molin TR, Viana C, de Carvalho LM. Determination of diuretics and laxatives as adulterants in herbal formulations for weight loss. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30:1230-7. https://doi.org/10.1080/19440049.2013.800649
  14. Campbell N, Clark JP, Stecher VJ, Thomas JW, Callanan AC, Donnelly BF, et al. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med. 2013;10:1842-9. https://doi.org/10.1111/jsm.12172
  15. Domenech-Carbo A, Martini M, de Carvalho LM, Viana C, Domenech-Carbo MT, Silva M. Screening of pharmacologic adulterant classes in herbal formulations using voltammetry of microparticles. J Pharm Biomed Anal. 2013;74:194-204. https://doi.org/10.1016/j.jpba.2012.10.031
  16. Khazan M, Hedayati M, Kobarfard F, Askari S, Azizi F. Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements. Iran Red Crescent Med J. 2014;16:e15344.
  17. Lee JH, Kim HJ, Noh E, Kim JY, Cho SH, Do JA, et al. Identification and screening of a tadalafil analogue found in adulterated herbal products. J Pharm Biomed Anal. 2015;103:80-4. https://doi.org/10.1016/j.jpba.2014.11.006
  18. Hachem R, Assemat G, Martins N, Balayssac S, Gilard V, Martino R, et al. Proton NMR for detection, identification and quantification of adulterants in 160 herbal food supplements marketed for weight loss. J Pharm Biomed Anal. 2016;124:34-47. https://doi.org/10.1016/j.jpba.2016.02.022
  19. Park HJ, Cho SH, Lee JH, Hwang IS, Han KM, Yoon CY, et al. Screening for Corticosteroid Adulterants in Korean Herbal Medicines. J Forensic Sci. 2016;61:226-9. https://doi.org/10.1111/1556-4029.12906
  20. Al Lawati HA, Al Busaidi I, Kadavilpparampu AM, Suliman FO. Determination of Common Adulterants in Herbal Medicine and Food Samples using Core-shell Column Coupled to Tandem Mass Spectrometry. J Chromatogr Sci. 2017;55:232-42. https://doi.org/10.1093/chromsci/bmw175
  21. Pascali JP, Fais P, Vaiano F, Bertol E. Application of HRAM screening and LC-MS/MS confirmation of active pharmaceutical ingredient in "natural" herbal supplements. Forensic Sci Int. 2018;286:e28-e31. https://doi.org/10.1016/j.forsciint.2018.03.014
  22. Shekari N, Vosough M, Tabar Heidar K. Chromatographic fingerprinting through chemometric techniques for herbal slimming pills: A way of adulterant identification. Forensic Sci Int. 2018;286:213-22. https://doi.org/10.1016/j.forsciint.2018.03.022
  23. Dastjerdi AG, Akhgari M, Kamali A, Mousavi Z. Principal component analysis of synthetic adulterants in herbal supplements advertised as weight loss drugs. Complement Ther Clin Pract. 2018;31:236-41. https://doi.org/10.1016/j.ctcp.2018.03.007
  24. Minh DTC, Thi LA, Huyen NTT, Van Vu L, Anh NTK, Ha PTT. Detection of sildenafil adulterated in herbal products using thin layer chromatography combined with surface enhanced Raman spectroscopy: "Double coffee-ring effect" based enhancement. J Pharm Biomed Anal. 2019;174:340-7. https://doi.org/10.1016/j.jpba.2019.05.043
  25. Crighton E, Coghlan ML, Farrington R, Hoban,, CL, Power MWP, Nash C, et al. Toxicological screening and DNA sequencing detects contamination and adulteration in regulated herbal medicines and supplements for diet, weight loss and cardiovascular health. J Pharm Biomed Anal. 2019;176:112834. https://doi.org/10.1016/j.jpba.2019.112834
  26. World Health Organization. WHO Global Report on Traditional and Complementary Medicine 2019. Luxembourg: World Health Organization; 2019.
  27. National Institute of Food and Drug Safety Evaluation. 2019 Investigation Analysis Archives of Food and Drug Vol 2. Cheongju: Ministry of Food and Drug Safety; 2019.
  28. National Institute of Food and Drug Safety Evaluation. 2019 Investigation Analysis Archives of Food and Drug Vol 1. Cheongju: Ministry of Food and Drug Safety; 2019.
  29. US Pharmacopoeia. Dietary Supplements Compendium(DS C). [Internet]. [cited 2020 Sep 04]. Available from: https://www.usp.org/products/dietary-supplements-compendium